{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:04:20Z","timestamp":1792728260458,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T00:00:00Z","timestamp":1485820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ijcard.2016.12.029","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T08:00:54Z","timestamp":1482480054000},"page":"155-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"special_numbering":"C","title":["Aldosterone Pathway Blockade to Prevent Atrial Fibrillation: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"231","author":[{"given":"J.","family":"Neefs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.W.E.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Limpens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.R.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Boekholdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.12.029_bb0005","series-title":"Developed with the special contribution of the European Heart Rhythm Association","first-page":"2719","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation","volume":"33","author":"Camm","year":"2012"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0010","first-page":"62","article-title":"Atrial remodeling and atrial fibrillation: mechanisms and implications","volume":"1","author":"Nattel","year":"2008","journal-title":"Circ. EP"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0015","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jacc.2015.06.1313","article-title":"Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications","volume":"66","author":"Dzeshka","year":"2015","journal-title":"JACC"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0020","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1016\/j.ijcard.2013.08.022","article-title":"Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural\/electrical remodeling","volume":"168","author":"Mayyas","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.tem.2015.01.007","article-title":"Emerging cardiovascular indications of mineralocorticoid receptor antagonists","volume":"26","author":"Parviz","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0030","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1074\/jbc.M113.519256","article-title":"The Mineralocorticoid Receptor Promotes Fibrotic Remodeling in Atrial Fibrillation","volume":"289","author":"Lavall","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0040","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"NEJM"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"NEJM"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0050","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0002-9149(01)01905-1","article-title":"Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation","volume":"88","author":"Goette","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1540-8159.2009.02673.x","article-title":"A decrease in serum aldosterone level is associated with maintenance of sinus rhythm after successful cardioversion of atrial fibrillation","volume":"33","author":"Wozakowska-Kaplon","year":"2010","journal-title":"PACE"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0065","series-title":"www.cochrane-handbook.org: The Cochrane Collaboration","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"Higgings","year":"2011"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0070","series-title":"The Newcastle-Ottawa Scale for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2014"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0075","first-page":"S262","article-title":"Effect of spironolactone on atrial fibrillation in patients with heart failure","volume":"1","author":"Brinkley","year":"2010","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0080","article-title":"Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy","author":"Chung","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0085","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.amjcard.2010.07.037","article-title":"Effect of combined spironolactone-beta-blocker \u00b1 enalapril treatment on occurrence of symptomatic atrial fibrillation episodes in patients with a history of paroxysmal atrial fibrillation (SPIR-AF study)","volume":"106","author":"Dabrowski","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0090","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cardfail.2006.11.015","article-title":"Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure","volume":"13","author":"Gao","year":"2007","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0095","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.amjcard.2012.12.020","article-title":"Effect of eplerenone on maintenance of sinus rhythm after catheter ablation in patients with long-standing persistent atrial fibrillation","volume":"111","author":"Ito","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0100","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/europace\/eup321","article-title":"Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion","volume":"11","author":"Kim","year":"2009","journal-title":"Europace"},{"issue":"380","key":"10.1016\/j.ijcard.2016.12.029_bb0105","article-title":"Electrical cardioversion at first episode of Atrial Fibrillation in patients with heart failure","volume":"33","author":"Marchetti","year":"2012","journal-title":"EHJ"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5152\/akd.2010.039","article-title":"Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction","volume":"10","author":"Ozaydin","year":"2010","journal-title":"Anadolu Kardiyol. Derg."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0115","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0003-3928(03)00089-1","article-title":"External electrical cardioversion of atrial arrhythmia: predictive criteria of success","volume":"52","author":"Paziaud","year":"2003","journal-title":"Ann. Cardiol. Angeiol."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0120","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1097\/CCM.0b013e31825b8be2","article-title":"Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery","volume":"40","author":"Pretorius","year":"2012","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0125","first-page":"31","article-title":"Effectiveness of aldosterone antagonists for preventing atrial fibrillation after cardiac surgery in patients with systolic heart failure: a retrospective study","volume":"104","author":"Simopoulos","year":"2015","journal-title":"Clin."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0130","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","article-title":"Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"JACC"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0135","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/clc.20914","article-title":"Effect of spironolactone on patients with atrial fibrillation and structural heart disease","volume":"34","author":"Williams","year":"2011","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0140","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ahj.2007.12.015","article-title":"Optimal heart failure therapy and successful cardioversion in heart failure patients with atrial fibrillation","volume":"155","author":"Boldt","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0145","first-page":"865","article-title":"Induction of cardiac fibrosis by aldosterone","volume":"32","author":"Lijnen","year":"2000","journal-title":"JMCC"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0150","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1074\/jbc.M113.519256","article-title":"The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation","volume":"289","author":"Lavall","year":"2014","journal-title":"JBC"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MED.0b013e3283391989","article-title":"Aldosterone and inflammation","volume":"17","author":"Gilbert","year":"2010","journal-title":"CO Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0160","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/europace\/euu040","article-title":"Antioxidants for prevention of atrial fibrillation: a potentially useful future therapeutic approach? A review of the literature and meta-analysis","volume":"16","author":"Violi","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0165","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1253\/circj.CJ-15-0138","article-title":"Role of inflammation in atrial fibrillation pathophysiology and management","volume":"79","author":"Harada","year":"2015","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2016.12.029_bb0170","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jacc.2009.09.045","article-title":"Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation","volume":"55","author":"Tsai","year":"2010","journal-title":"JACC"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0175","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0180","article-title":"Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis","author":"Liu","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2016.12.029_bb0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pharmthera.2015.06.009","article-title":"Inflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery","volume":"154","author":"Zakkar","year":"2015","journal-title":"Pharmacol. Ther."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316325773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316325773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T17:44:46Z","timestamp":1568655886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316325773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":37,"alternative-id":["S0167527316325773"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.12.029","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aldosterone Pathway Blockade to Prevent Atrial Fibrillation: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.12.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}